After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Immunome Inc is $845.12M. A total of 0.68 million shares were traded on the day, compared to an average of 773.66K shares.
In the most recent transaction, SIEGALL CLAY B bought 66,057 shares of IMNM for 9.54 per share on Nov 21 ’24. After the transaction, the President and CEO now owns 485,693 company shares. In a previous transaction on Nov 22 ’24, SIEGALL CLAY B bought 33,943 shares at 9.78 per share. IMNM shares that President and CEO owns now total 519,636.
Among the insiders who bought shares, Lechleider Robert acquired of 15,805 shares on Nov 21 ’24 at a per-share price of $9.48. This resulted in the Chief Medical Officer holding 15,805 shares of IMNM after the transaction. In another insider transaction, Tsai Philip bought 21,000 shares at $9.43 per share on Nov 21 ’24. Company shares held by the Chief Technology Officer now total 21,000.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IMNM has a high of $30.96 and a low of $6.93.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IMNM’s latest balance sheet shows that the firm has $49.23M in Cash & Short Term Investments as of fiscal 2021. There were $317.00k in debt and $9.73M in liabilities at the time. Its Book Value Per Share was $3.56, while its Total Shareholder’s Equity was $48.19M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMNM is Buy with a score of 5.00.
